Cargando…

Comparative Studies on Retroviral Proteases: Substrate Specificity

Exogenous retroviruses are subclassified into seven genera and include viruses that cause diseases in humans. The viral Gag and Gag-Pro-Pol polyproteins are processed by the retroviral protease in the last stage of replication and inhibitors of the HIV-1 protease are widely used in AIDS therapy. Res...

Descripción completa

Detalles Bibliográficos
Autor principal: Tözsér, József
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185560/
https://www.ncbi.nlm.nih.gov/pubmed/21994605
http://dx.doi.org/10.3390/v2010147
_version_ 1782213232994287616
author Tözsér, József
author_facet Tözsér, József
author_sort Tözsér, József
collection PubMed
description Exogenous retroviruses are subclassified into seven genera and include viruses that cause diseases in humans. The viral Gag and Gag-Pro-Pol polyproteins are processed by the retroviral protease in the last stage of replication and inhibitors of the HIV-1 protease are widely used in AIDS therapy. Resistant mutations occur in response to the drug therapy introducing residues that are frequently found in the equivalent position of other retroviral proteases. Therefore, besides helping to understand the general and specific features of these enzymes, comparative studies of retroviral proteases may help to understand the mutational capacity of the HIV-1 protease.
format Online
Article
Text
id pubmed-3185560
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-31855602011-10-12 Comparative Studies on Retroviral Proteases: Substrate Specificity Tözsér, József Viruses Review Exogenous retroviruses are subclassified into seven genera and include viruses that cause diseases in humans. The viral Gag and Gag-Pro-Pol polyproteins are processed by the retroviral protease in the last stage of replication and inhibitors of the HIV-1 protease are widely used in AIDS therapy. Resistant mutations occur in response to the drug therapy introducing residues that are frequently found in the equivalent position of other retroviral proteases. Therefore, besides helping to understand the general and specific features of these enzymes, comparative studies of retroviral proteases may help to understand the mutational capacity of the HIV-1 protease. Molecular Diversity Preservation International (MDPI) 2010-01-14 /pmc/articles/PMC3185560/ /pubmed/21994605 http://dx.doi.org/10.3390/v2010147 Text en © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Tözsér, József
Comparative Studies on Retroviral Proteases: Substrate Specificity
title Comparative Studies on Retroviral Proteases: Substrate Specificity
title_full Comparative Studies on Retroviral Proteases: Substrate Specificity
title_fullStr Comparative Studies on Retroviral Proteases: Substrate Specificity
title_full_unstemmed Comparative Studies on Retroviral Proteases: Substrate Specificity
title_short Comparative Studies on Retroviral Proteases: Substrate Specificity
title_sort comparative studies on retroviral proteases: substrate specificity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185560/
https://www.ncbi.nlm.nih.gov/pubmed/21994605
http://dx.doi.org/10.3390/v2010147
work_keys_str_mv AT tozserjozsef comparativestudiesonretroviralproteasessubstratespecificity